Regulation of the human cathepsin E gene by the constitutive androstane receptor

Archives of Biochemistry and Biophysics

Volumn 467, Issue 1, 2007, Pages 132-138

  Page, Jeanine L ^a   Strom, Stephen C ^b   Omiecinski, Curtis J ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cathepsin E; Constitutive androstane receptor; Hepatocytes; Human; Liver; Primary hepatocytes

Indexed keywords

CATHEPSIN E; CONSTITUTIVE ANDROSTANE RECEPTOR; PHENOBARBITAL; RETINOID X RECEPTOR ALPHA;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CATHEPSIN E GENE; CELL CULTURE; DNA FLANKING REGION; DNA MICROARRAY; ENZYME ACTIVITY; ENZYME ASSAY; GENE; GENE CONTROL; GENE IDENTIFICATION; GENE TARGETING; INNATE IMMUNITY; LIVER CARCINOGENESIS; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR PROMOTION;

AMINO ACID MOTIFS; CARCINOMA; CATHEPSIN E; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; LIVER; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOBARBITAL; PROMOTER REGIONS (GENETICS); RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 35448976355     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2007.08.001     Document Type: Article

References (39)

1. Tatnell P.J., Fowler S.D., Bur D., Lees W.E., and Kay J. Adv. Exp. Med. Biol. 436 (1998) 147-152
2. Saku T., Sakai H., Shibata Y., Kato Y., and Yamamoto K. J. Biochem. (Tokyo). 110 (1991) 956-964
3. Bennett K., Levine T., Ellis J.S., Peanasky R.J., Samloff I.M., Kay J., and Chain B.M. Eur. J. Immunol. 22 (1992) 1519-1524
4. Tsukuba T., Okamoto K., Okamoto Y., Yanagawa M., Kohmura K., Yasuda Y., Uchi H., Nakahara T., Furue M., Nakayama K., Kadowaki T., Yamamoto K., and Nakayama K.I. J. Biochem. (Tokyo). 134 (2003) 893-902
5. Tsukuba T., Yamamoto S., Yanagawa M., Okamoto K., Okamoto Y., Nakayama K.I., Kadowaki T., and Yamamoto K. J. Biochem. (Tokyo). 140 (2006) 57-66
6. Yanagawa M., Tsukuba T., Nishioku T., Okamoto Y., Okamoto K., Takii R., Terada Y., Nakayama K.I., Kadowaki T., and Yamamoto K. J. Biol. Chem. 282 (2007) 1851-1862
7. Briozzo P., Morisset M., Capony F., Rougeot C., and Rochefort H. Cancer Res. 48 (1988) 3688-3692
8. Finley E.M., and Kornfeld S. J. Biol. Chem. 269 (1994) 31259-31266
9. Marin H.E., Peraza M.A., Billin A.N., Willson T.M., Ward J.M., Kennett M.J., Gonzalez F.J., and Peters J.M. Cancer Res. 66 (2006) 4394-4401
10. Lewis B.C., Klimstra D.S., Socci N.D., Xu S., Koutcher J.A., and Varmus H.E. Mol. Cell. Biol. 25 (2005) 1228-1237
11. Matsuo K., Kobayashi I., Tsukuba T., Kiyoshima T., Ishibashi Y., Miyoshi A., Yamamoto K., and Sakai H. Hum. Pathol. 27 (1996) 184-190
12. Terris B., Blaveri E., Crnogorac-Jurcevic T., Jones M., Missiaglia E., Ruszniewski P., Sauvanet A., and Lemoine N.R. Am. J. Pathol. 160 (2002) 1745-1754
13. Shiraishi T., Samloff I.M., Taggart R.T., and Stemmermann G.N. Dig. Dis. Sci. 33 (1988) 1466-1472
14. Cook M., Caswell R.C., Richards R.J., Kay J., and Tatnell P.J. Eur. J. Biochem. 268 (2001) 2658-2668
15. Yasuda Y., Kohmura K., Kadowaki T., Tsukuba T., and Yamamoto K. Biol. Chem. 386 (2005) 299-305
16. Page J., Johnson M., Olsavsky K., Strom S., Zarbl H., and Omiecinski C. Toxicol. Sci. (2007)
17. Auerbach S.S., Stoner M.A., Su S., and Omiecinski C.J. Mol. Pharmacol. 68 (2005) 1239-1253
18. Luckow B., and Schutz G. Nucleic Acids Res 15 (1987) 5490
19. Sandelin A., and Wasserman W.W. Mol. Endocrinol. 19 (2005) 595-606
20. Honkakoski P., Zelko I., Sueyoshi T., and Negishi M. Mol. Cell. Biol. 18 (1998) 5652-5658
21. Kawamoto T., Sueyoshi T., Zelko I., Moore R., Washburn K., and Negishi M. Mol. Cell. Biol. 19 (1999) 6318-6322
22. Auerbach S.S., Ramsden R., Stoner M.A., Verlinde C., Hassett C., and Omiecinski C.J. Nucleic Acids Res. 31 (2003) 3194-3207
23. Jinno H., Tanaka-Kagawa T., Hanioka N., Ishida S., Saeki M., Soyama A., Itoda M., Nishimura T., Saito Y., Ozawa S., Ando M., and Sawada J. Mol. Pharmacol. 65 (2004) 496-502
24. Lamba V., Yasuda K., Lamba J.K., Assem M., Davila J., Strom S., and Schuetz E.G. Toxicol. Appl. Pharmacol. 199 (2004) 251-265
25. Savkur R.S., Wu Y., Bramlett K.S., Wang M., Yao S., Perkins D., Totten M., Searfoss III G., Ryan T.P., Su E.W., and Burris T.P. Mol. Genet. Metab. 80 (2003) 216-226
26. Makinen J., Frank C., Jyrkkarinne J., Gynther J., Carlberg C., and Honkakoski P. Mol. Pharmacol. 62 (2002) 366-378
27. Moore L.B., Parks D.J., Jones S.A., Bledsoe R.K., Consler T.G., Stimmel J.B., Goodwin B., Liddle C., Blanchard S.G., Willson T.M., Collins J.L., and Kliewer S.A. J. Biol. Chem. 275 (2000) 15122-15127
28. Moore L.B., Maglich J.M., McKee D.D., Wisely B., Willson T.M., Kliewer S.A., Lambert M.H., and Moore J.T. Mol. Endocrinol. 16 (2002) 977-986
29. Huang W., Zhang J., Wei P., Schrader W.T., and Moore D.D. Mol. Endocrinol. 18 (2004) 2402-2408
30. Yee C.S., Yao Y., Li P., Klemsz M.J., Blum J.S., and Chang C.H. J. Immunol. 172 (2004) 5528-5534
31. Llovet J.M., Burroughs A., and Bruix J. Lancet 362 (2003) 1907-1917
32. Pitot H.C. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 465-500
33. Yamamoto Y., Moore R., Goldsworthy T.L., Negishi M., and Maronpot R.R. Cancer Res. 64 (2004) 7197-7200
34. Handschin C., and Meyer U.A. Pharmacol. Rev. 55 (2003) 649-673
35. Maglich J.M., Parks D.J., Moore L.B., Collins J.L., Goodwin B., Billin A.N., Stoltz C.A., Kliewer S.A., Lambert M.H., Willson T.M., and Moore J.T. J. Biol. Chem. 278 (2003) 17277-17283
36. Rochefort H., Capony F., Garcia M., Cavailles V., Freiss G., Chambon M., Morisset M., and Vignon F. J. Cell. Biochem. 35 (1987) 17-29
37. Rochefort H., Capony F., and Garcia M. Cancer Metast. Rev. 9 (1990) 321-331
38. Whysner J., Ross P.M., and Williams G.M. Pharmacol. Ther. 71 (1996) 153-191
39. Pitot H.C., Barsness L., Goldsworthy T., and Kitagawa T. Nature 271 (1978) 456-458